CA Patent

CA2770211A1 — Methods for iontophoretically treating nausea and migraine

Assigned to NuPathe Inc · Expires 2011-02-17 · 15y expired

What this patent protects

Methods for treating nausea and migraine by iontophoretically administering triptan compounds are provided.

USPTO Abstract

Methods for treating nausea and migraine by iontophoretically administering triptan compounds are provided.

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: CA2770211A1
Jurisdiction: CA
Classification: —
Expires: 2011-02-17
Drug substance claim: No
Drug product claim: No
Assignee: NuPathe Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.